812.212.21 VAMOMÉDOM

CH

Art. 42 Verordnung vom 21. September 2018 über die Arzneimittel (VAM) - Abgabe auf ärztliche oder tierärztliche Verschreibung

VAM; 3. Kapitel: Abgabekategorien und Abgabe

Originalquelle öffnen Gesamter Erlass (94 Artikel) Maschinenlesbares Markdown (.md)

Art. 42 VAM · Abgabe auf ärztliche oder tierärztliche Verschreibung

Ein Arzneimittel wird in die Kategorie der verschreibungspflichtigen Arzneimittel (Abgabekategorie B) eingeteilt, wenn: a. es gegen Krankheiten empfohlen wird, für deren Behandlung eine ärztliche oder tierärztliche Diagnose oder Überwachung erforderlich ist; b. es bei bestimmungsgemässem Gebrauch ohne ärztliche oder tierärztliche Diagnose oder Überwachung die Gesundheit direkt oder indirekt gefährden kann; c. es häufig nicht bestimmungsgemäss verwendet wird und dies die Gesundheit direkt oder indirekt gefährden kann; d. es Wirkstoffe oder Zubereitungen aus Wirkstoffen enthält, deren Wirkungen und unerwünschte Wirkungen noch genauer erforscht werden müssen; e. es zur parenteralen Anwendung bestimmt ist; f. seine Abgabe die Fachberatung durch eine Medizinalperson erfordert.

← Art. 41 VAM Verordnung vom 21. September 2018 über die Arzneimittel (VAM) Art. 43 VAM →

Gerichtsentscheide zu dieser Bestimmung (10)

C-1678/2020 (Art. 42 let. c VAM)

Diphenhydramine Sleep Aid Reclassification Upheld

Used as the legal basis for reclassifying the drug B._______ into dispensing category B due to its potential for misuse and frequent non-conforming use that could endanger health.

C-4738/2019 (Art. 42 Bst. f VAM)

Pharmaceutical Company v. Drug Authority: Reclassification and Fee Dispute

Cited as a criterion for classifying a medicinal product into category B, requiring advice from a medical professional.

C-3188/2019 (Art. 42 Bst. b und c VAM)

Drug Reclassification: Safety Concerns Override Broader Access

Used to justify the classification in dispensing category B due to the drug's safety profile and potential risks.

C-3188/2019 (Art. 42 Bst. f VAM)

Drug Reclassification: Safety Concerns Override Broader Access

Used as a criterion for classifying the drug in dispensing category B due to the requirement of specialist advice from a medical professional.

C-4968/2019 (Art. 42 let. c OMéd)

Reclassification of Medications Upheld Due to Recreational Misuse and Health Risks

This provision is the main ground for reclassifying the medications into category B due to frequent non-compliant use posing a health risk.

C-1050/2020 (Art. 42 Bst. c VAM)

Pharmaceutical Company v. Reclassification of Sleep Medication

This provision served as the legal basis for reclassifying the medicine into category B due to frequent misuse that could endanger health.

C-5010/2019 (Art. 42 Bst. c VAM)

Medication Reclassification Upheld Due to Safety Concerns

This provision was used to determine that the conditions for reclassifying the medicines into category B were met due to frequent non-intended use that could endanger health.

C-5010/2019 (Art. 42 Bst. f VAM)

Medication Reclassification Upheld Due to Safety Concerns

This provision was cited as a criterion for reclassifying medicines into category B when their dispensing requires professional advice from a medical professional.

C-5006/2019 (Art. 42 Bst. c VAM)

Medication Reclassification and Administrative Fees Upheld

The main ground for the verdict, used to determine that the medicinal product B._______, Sirup, met the criteria for reclassification into Abgabekategorie B due to frequent non-conformist use and potential health risks.

C-5006/2019 (Art. 42 Bst. f VAM)

Medication Reclassification and Administrative Fees Upheld

The provision stating that a medicinal product is classified into Abgabekategorie B if its dispensing requires specialist advice from a medical professional, which was discussed but found not to be a sufficient standalone criterion.